Department of Biotechnology
inStem (Institute for Stem Cell Science and Regenerative Medicine)

Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region.

Publication Type

Research Support, Non-U.S. Gov't

Date of Publication

October 17, 2017

Journal

Proceedings of the National Academy of Sciences of the United States of America

Volume/Issue

114/42

ISSN

1091-6490

Point mutations in genes encoding sarcomeric proteins are the leading cause of inherited primary cardiomyopathies. Among them are mutations in the gene that encodes cardiac troponin T (TnT). These mutations are clustered in the tropomyosin (Tm) binding region of TnT, TNT1 (residues 80-180). To understand the mechanistic changes caused by pathogenic mutations in the TNT1 region, six hypertrophic cardiomyopathy (HCM) and two dilated cardiomyopathy (DCM) mutants were studied by biochemical approaches. Binding assays in the absence and presence of actin revealed changes in the affinity of some, but not all, TnT mutants for Tm relative to WT TnT. HCM mutants were hypersensitive and DCM mutants were hyposensitive to Ca in regulated actomyosin ATPase activities. To gain better insight into the disease mechanism, we modeled the structure of TNT1 and its interactions with Tm. The stability predictions made by the model correlated well with the affinity changes observed in vitro of TnT mutants for Tm. The changes in Ca sensitivity showed a strong correlation with the changes in binding affinity. We suggest the primary reason by which these mutations between residues 92 and 144 cause cardiomyopathy is by changing the affinity of TnT for Tm within the TNT1 region.

Alternate Journal

Proc Natl Acad Sci U S A

PubMed ID

28973951

PubMed Central ID

PMC5651771

Authors

Binnu Gangadharan
Margaret S Sunitha
Souhrid Mukherjee
Ritu Roy Chowdhury
Farah Haque
Narendrakumar Sekar
Ramanathan Sowdhamini
James A Spudich
John A Mercer

Keywords

Humans
Tropomyosin
Mutation
Troponin T
Escherichia coli
Actins
Calcium
Cardiomyopathy, Hypertrophic
Molecular Structure
Cardiomyopathy, Dilated
Models, Chemical